Home>Boao Super Hospital
Boao Super Hospital
Boao Super Hospital [Photo by Boao Hope City]
Boao Super Hospital is located in the Boao Lecheng International Medical Tourism Pilot Zone, and enjoys a package of favorable policies in terms of medical technology access, and medical device and drug import registration. Adopting the innovative "1+x" sharing model, the hospital has successfully attracted many academicians and top-class Chinese medical experts. Shulan Health is in charge of the hospital's daily operations and management.
Boao Super Hospital has attracted a large number of high-end medical experts thanks to its excellent sharing platform and open medical concept. The medical teams include Academician Li Lanjuan of the Department of Infectious Diseases, Academician Zheng Shusen of Hepatobiliary Surgery, Professor Zhang Xuejun of Dermatology, Academician Dong Jiahong of Hepatobiliary Surgery, Academician Zhang Zhiyuan of Oral and Maxillofacial Surgery, Academician Sun Yinghao of the Department of Urology, Academician Ning Guang of the Department of Endocrinology, Academician Li Zhaoshen of the Department of Gastroenterology, Academician Wang Chen of the Department of Respiratory Medicine, Academician Han Demin of the Department of Otorhinolaryngology, Professor Wu Hao of the Department of Otorhinolaryngology, Academician Ge Junbo of the Department of Cardiology, Professor Zhang Shu of the Department of Cardiology, Professor Qu Jia of the Department of Ophthalmology, Professor Li Qingfeng of Plastic Surgery, Professor Shao Yongfu of the Department of Oncology, Professor Li Mingding of Precision Diagnosis, Professor Xiang Chunsheng of the Stem Cell and Frontier Technology Application Transformation Center, and the medical team of United Family Healthcare.
In addition, eight academician workstations in the hospital are known collectively as the Hainan Academician Workstation. Over 200 operations were performed from the hospital's opening on March 31, 2018 to July 2019.
The hospital was the first to perform the 14 following operations or treatments in China or in the Chinese mainland: a domestically licensed Boston type I keratoprosthesis, a licensed MEDEL cochlear implant, a licensed clinical application of a Medtronic Bluetooth pacemaker, clinical application of a COMBO stent, licensed import of secukinumab to treat psoriasis, nine-valent cervical cancer vaccine injection, full-range visual and magnetic-electric dual-position cardiac surgery, market-oriented implantation of a Micra TPS leadless pacemaker, a magnetically compatible cardiac treatment and cardioverter defibrillator implantation, an atopic dermatitis targeted biologic agent Dupixent injection, a minimally invasive glaucoma drainage tube implantation, a licensed Boston type II keratoprosthesis, and YUTIQTM (Fluocinolone acetonide intravitreal implant) injection. It was also the first in China to use the world leading Abbott EnSite Precision cardiac mapping system, TactiCath SE catheter, and Advisor HD Grid SE.